#Hong Kong #Medtronic #Surgical Robotics #Cornerstone Robotics

Cornerstone Robotics and Medtronic Join Forces

In a significant development for the surgical robotics field, Cornerstone Robotics, a cutting-edge company in surgical robotics based in Hong Kong, has announced a strategic partnership with Medtronic (NYSE: MDT), a global leader in healthcare technology. This collaboration is set to bridge the gap in access to advanced robotic-assisted surgery across the globe.

A Transformative Investment

Medtronic will invest approximately $700 million in Cornerstone Robotics, gaining the rights to distribute its innovative Sentire™ surgical system in select markets outside the United States where the system is approved. This investment not only underscores Medtronic's commitment to enhancing healthcare technology but also aims to facilitate the wider adoption of robotic surgery procedures in diverse healthcare settings.

Addressing Global Surgery Gaps

Currently, robotic-assisted surgery is underutilized worldwide, presenting significant potential for improving surgical care for patients, healthcare providers, and systems worldwide. Both companies aim to leverage their strengths, with Cornerstone's innovative technology coupled with Medtronic's extensive global reach, to enhance readiness and access to high-quality robotic surgical solutions.

Strengthening Technological Capabilities

Cornerstone Robotics has established a solid strategic posture through its full-stack in-house research and development, as well as a vertically integrated business model. By developing core hardware, control software, and advanced imaging and energy platforms internally, Cornerstone maintains robust control over product integration, quality assurance, and supply chain resilience. This, in turn, solidifies the stability and performance of the Sentire surgical system under complex clinical conditions.

The Sentire system received approval from the National Medical Products Administration in China in 2024, followed by CE marking in the EU and clearance from the Health Sciences Authority in Singapore in May 2026. These approvals encompass minimally invasive procedures in general, gynecological, thoracic, and urological surgery, allowing for broader application in various surgical specialties.

A Vision for Global Access

Professor Kwok Wai Samuel AU, Founder and CEO of Cornerstone Robotics, described the partnership as a crucial move toward advancing global access to robotic surgery. He highlighted the existing gap between the rising demand for minimally invasive surgical solutions and the technology available. Through this partnership, Cornerstone anticipates accelerating innovation in surgical robotics, ultimately making the benefits of advanced surgery available to more surgeons and patients worldwide.

Moreover, Matt Anderson, Senior Vice President and President of the Surgical business at Medtronic, mentioned that this investment and distribution agreement enhances Medtronic's capability to expand access to minimally invasive procedures globally. He emphasized that adding Sentire to their Hugo robotic platform offers more options in robotic-assisted surgery.

A Synergistic Future

This partnership marks a significant milestone for both organizations, aligning with their mutual commitment to making robotic surgery accessible globally. Cornerstone's focus on continuous innovation empowers them to advance surgical robot technologies, while Medtronic's vast infrastructure allows for the distribution and scaling of surgical innovations.

Conclusion

In conclusion, Cornerstone Robotics and Medtronic's collaboration signifies a robust commitment to transforming the surgical landscape. By aligning resources and expertise, they aim to close the existing gaps in robotic-assisted surgery access, ultimately enhancing patient outcomes and providing solutions to complex global health challenges.

For further information on Cornerstone Robotics and its innovative solutions, visit Cornerstone Robotics. Similarly, learn more about Medtronic’s groundbreaking initiatives at Medtronic.